Halbert Hargrove Global Advisors, LLC Gilead Sciences, Inc. Transaction History
Halbert Hargrove Global Advisors, LLC
- $1.76 Billion
- Q1 2025
A detailed history of Halbert Hargrove Global Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Halbert Hargrove Global Advisors, LLC holds 144 shares of GILD stock, worth $15,023. This represents 0.0% of its overall portfolio holdings.
Number of Shares
144
Previous 76
89.47%
Holding current value
$15,023
Previous $7,000
128.57%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,130Shares Held
988MCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$12.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.1 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.48 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.3 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.05 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $131B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...